Swan EndoSurgical names longtime Stryker executive Erik Todd as CEO

Swan EndoSurgical has appointed Erik Todd, a veteran medical technology leader with more than 25 years at Stryker Corp., as its new chief executive officer, the company announced.

Todd most recently served as vice president and general manager of Stryker’s Robotics and Enabling Technologies division. The company said his background in scaling advanced robotic platforms, building global engineering teams, and driving innovation in endoscopy and minimally invasive surgery will support Swan’s push to commercialize a flexible endoluminal surgical robotics platform for complex gastrointestinal interventions.

“Erik is an accomplished and respected leader in surgical robotics,” said Justin Ballotta, managing director at Revival Healthcare Capital and head of post-investment value creation. “With a proven track record of scaling sophisticated robotics platforms from concept through commercialization, Erik brings a global perspective, strategic rigor, and a deep appreciation for clinical needs making him the ideal leader for Swan.”

Swan EndoSurgical is backed by Revival Healthcare Capital and Olympus Corporation. The company was co-founded by the two organizations to advance a robotic system designed to improve the treatment of lesions and tumors in the gastrointestinal tract.

“The appointment of Erik to Swan EndoSurgical as the CEO marks a pivotal step in advancing our shared vision for endoluminal robotics,” said Bob White, representative executive officer, president and chief executive officer at Olympus Corporation. “Together, we are committed to transforming gastrointestinal care through breakthrough robotics, empowering physicians, and delivering safer, less invasive solutions for patients everywhere.”

Todd said he is eager to work with Swan’s partners and clinical stakeholders to move the company’s technology forward. “I am excited to join Swan EndoSurgical and help advance endoluminal surgery,” he said. “Building on the foundation created by Swan, Revival, and Olympus, we can address unmet needs in advanced GI interventions using robotics, visualization, and flexible access. I look forward to collaborating with Olympus, health care professionals, and our teams to develop, deliver, and scale meaningful innovations for patients around the world.”